Overview
This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.
Description
PRIMARY OBJECTIVES:
I. Evaluate the feasibility and acceptability of a 3-month EMA protocol in AYA sarcoma survivors.
II. Quantify variability in pain and opioid use over a 3-month period for AYA sarcoma survivors.
III. Identify associations between biopsychosocial mechanisms (e.g., pain beliefs, worry) and pain and opioid use outcomes.
OUTLINE: This is an observational study.
Patients complete baseline questionnaires, daily EMA surveys and an interview on study.
Eligibility
Inclusion Criteria:
- All genders between the ages of 12-24 (inclusive) at sarcoma diagnosis.
- Any age \< 70 at the time of study enrollment.
- No evidence of disease and/or enrolled in survivorship care.
- Clinically meaningful pain related to disease or its treatments at baseline (defined as 3 or greater on a 0-10 Numerical Rating Scale).
- Willing to attend the baseline appointment in person.
- Access to internet-capable smartphone.
- Access to internet on an occasional basis.
- Willing and able to complete Ecological Momentary Assessments (EMAs) on internet-capable smartphone for a 3-month period after enrollment.
- Ability to understand and provide informed consent/assent.
Exclusion Criteria:
- \* Currently receiving active cancer-directed therapy.
- Unable to read or fluently speak English.
- Determined by clinical staff to have preexisting or cancer-associated cognitive impairment that could interfere with study participation.
- Acutely suicidal (e.g. intent or plan) or, with unstable medical or psychiatric condition verified by licensed study staff.
- Characteristics related to inability to complete the study protocol.
